close 74% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

Strona główna・Stock List・Jazz Pharmaceuticals PLC
Search

Jazz Pharmaceuticals PLC

Open

SectorHealthcare

139.82 2.16

Strong Buy

Price update 3 paź 2025, 14:31 UTC

BuySell

Overview

Share price change

24h

Current

Min

136.24

Max

140.12

Key metrics

By Trading Economics

Income

-626M

-718M

Sales

148M

1B

P/E

Sector Avg

15.775

35.739

Profit margin

-68.706

Employees

2,800

EBITDA

-623M

-514M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+35.14% upside

Market Stats

By TradingEconomics

Market Cap

801M

7.8B

Previous open

137.66

Previous close

139.82

News Sentiment

By Acuity

20%

80%

36 / 371 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

N/A / 111.22 Support & Resistance

Jazz Pharmaceuticals PLC Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

21 lis 2024, 14:45 UTC

Major Market Movers

Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK

DJ

Read

31 paź 2024, 15:29 UTC

Major Market Movers

Avadel Pharma Shares Rise on Favorable Ruling for FDA in Lumryz Litigation

DJ

Read

Peer Comparison

Price change

Jazz Pharmaceuticals PLC Forecast

Price Target

By TipRanks

35.14% upside

12 Months Forecast

Average 185 USD  35.14%

High 230 USD

Low 147 USD

Based on 14 Wall Street analysts offering 12 month price targets forJazz Pharmaceuticals PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

14 ratings

14

Buy

0

Hold

0

Sell

Based on 14 analysts giving stock ratings to Jazz Pharmaceuticals PLC - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 111.22Support & Resistance

Short Term

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Long Term

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

36 / 371 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

MDT

Medtronic PLC

97.25

↑ +1.88%

VEEV

Veeva Systems Inc

300.62

↑ +4.11%

A

Agilent Technologies Inc

139.72

↓-0.04%

HQY

HealthEquity Inc

90.34

↓-0.32%

PHR.US

Phreesia Inc

23.41

↑ +5.4%
help-icon Live chat